Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 64
	QLoRA Alpha: 64.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an indicator of malnutrition and has been shown to be more strongly associated with neonatal morbidity than birth weight percentiles. Therefore, we recommend using BF% as the primary measure of undernutrition in neonates. Although both measures are interrelated, BF% provides additional information regarding the impact of undernutrition on the neonate. It may be particularly useful when assessing preterm or small for gestational age infants. Further studies should investigate whether BF% could be used to identify high-risk neonates in whom interventions can be targeted. Our data suggest that BF% may have greater clinical utility than birth weight percentiles. However, these findings require confirmation in future studies.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant's answer correctly states that low BF% was more strongly associated with neonatal morbidity than birth weight percentiles and appropriately notes further confirmation is needed. However it overreaches by recommending BF% as the primary clinical measure based on a single study and incorrectly suggests applicability to preterm infants, whereas the study population was term neonates. It also omits the useful nuance that BF% can identify neonates who are appropriately grown by weight but undernourished and can exclude small neonates who are not at risk.

conciseness: 0.7
Reasoning:
The assistant's reply is generally concise and directly answers the question by stating that BF% is more strongly associated with neonatal morbidity and recommending BF% as the preferred measure. However, it includes some redundant phrasing and an unnecessary/inaccurate aside about preterm infants (the study sampled term neonates), and it slightly overstates a policy recommendation based on a single study.

relevance: 0.4
Reasoning:
The assistant's reply is relevant in that it directly answers the question (saying BF% is a better indicator) and refers to the study's finding that BF% was more strongly associated with neonatal morbidity. However, it fails to quote or explicitly cite the actual results from the context (e.g., the reported ORs or that the study included only term neonates), and it oversteps by recommending BF% as the primary clinical measure and by suggesting usefulness in preterm infants despite the study being limited to term neonates. Overall the answer is partially relevant but includes unsupported extrapolation and omitted specific contextual references.

coherence: 0.6
Reasoning:
The assistant's reply is mostly coherent and well-structured: it directly answers the question, states the main finding (BF% is more strongly associated with neonatal morbidity), and adds appropriate caveats about needing further study. However, it overgeneralizes and slightly misrepresents the study: it recommends BF% as the "primary" measure and suggests usefulness for preterm infants despite the study including only term neonates, and it omits quantitative details and limitations that would temper the recommendation. Overall clear but somewhat overconfident and imprecise.

helpfulness: 0.4
Reasoning:
The response correctly states the study's main conclusion that neonatal body fat percentage (BF%) is more strongly associated with neonatal morbidity than birth weight percentiles and that BF% can add information about undernutrition. However, it overstates the practical recommendation by unconditionally recommending BF% as the primary measure and incorrectly suggests usefulness for preterm infants despite the study including only term neonates (≥37 wk). It also omits key specifics (effect sizes, identified rates) and does not discuss feasibility or study limitations (sample size, measurement method—air displacement plethysmography). Because of these factual and interpretive shortcomings, the answer is only partially reliable.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The management of ischemic Charcot neuroarthropathy is different from the management of other types of Charcot neuropathies. We recommend early diagnosis and treatment as soon as possible to avoid severe complications such as major amputations. Endovascular revascularization and surgery may be performed in selected cases. The success rate of this technique is high and we have achieved good results. However, the use of antibiotic prophylaxis is mandatory to prevent infections, which are frequent in these patients. Proper preoperative and postoperative treatment, including the use of antibiotics, should be considered before the start of surgery. In addition, close follow up is recommended to monitor the wound status, to detect any infection or nonunion of the bone fractures and to treat accordingly. Finally, it is important to consider the use of hyperbaric oxygen therapy in case of nonhealing ulcers, deep soft tissue infections, delayed healing, delayed wound closure and poor wound status. The decision to perform surgery must be made on a case by case basis taking into account the severity of the disease, the patient's general condition, and the experience of the operator. The indication for surgery should always be evaluated in conjunction with the clinical picture and the patient's symptoms. Moreover, the patient's medical history, physical examination, laboratory test results and radiologic findings must also be taken into account when planning the surgical approach. The aim of surgery is to obtain a stable anatomical reconstruction of the foot with optimal function and minimal risk of recurrence of the disease.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The response correctly identifies that ischemic Charcot foot requires different management than nonischemic Charcot (noting need for revascularization to enable surgical/orthopedic treatment and limb salvage) and emphasizes early diagnosis, individualized decision-making, and close follow-up. However, it contains overstated or unsupported claims (e.g., calling antibiotic prophylaxis "mandatory" in all cases, asserting hyperbaric oxygen as a general recommendation, and making vague "we have achieved good results" statements without data). It also fails to reference the study outcomes (limb-salvage rate, healing time) shown in the provided context. Overall the answer is partly correct but imprecise and sometimes clinically overgeneralized.

conciseness: 0.3
Reasoning:
Explanation: The assistant's reply contains relevant points (ischemic Charcot needs different management; revascularization and surgery can be used; close follow-up) but is wordy, repetitive and not tightly focused on the core distinction asked (that ischemic Charcot usually requires revascularization to support orthopedic/surgical treatment and enable limb salvage). It also includes some extraneous or potentially inaccurate blanket statements (e.g., "antibiotic prophylaxis is mandatory," routine hyperbaric oxygen) rather than a concise, evidence-focused statement. Overall it answers the question but lacks concision and precision.

relevance: 0.4
Reasoning:
The assistant's reply addresses the question by stating that ischemic Charcot neuroarthropathy is managed differently and mentioning endovascular revascularization plus surgery as treatment options. However, it does not reference or quote key findings from the provided context (for example the study's reported 90% limb-salvage rate and mean healing time), and it adds recommendations (e.g., mandatory antibiotic prophylaxis, routine hyperbaric oxygen) that are not supported or described in the supplied text. Overall it is relevant to the question but fails to ground its claims in the given evidence and includes unsupported assertions.

coherence: 0.7
Reasoning:
The response is generally coherent and organized: it directly answers the question by stating that ischemic Charcot neuroarthropathy requires different management, and it outlines relevant clinical actions (early diagnosis, revascularization, surgery selection, antibiotics, close follow-up). Weaknesses for coherence and clarity include some repetition (multiple mentions of antibiotics and individualized decision-making), vague/unqualified recommendations (e.g., “antibiotic prophylaxis is mandatory,” endorsement of hyperbaric oxygen without context), and an unnecessary first-person claim (“we have achieved good results”) that reduces objectivity. The reply also misses an opportunity to cite or summarize the study outcomes (limb salvage rate, healing time) that would have grounded the recommendations.

helpfulness: 0.6
Reasoning:
Explanation: The response correctly recognizes that ischemic Charcot neuroarthropathy requires different management and emphasizes early diagnosis, individualized decision-making, revascularization and surgical/orthopedic treatment — which aligns broadly with the ground truth. However, it is imprecise about the necessity of revascularization (saying it "may" be performed rather than that revascularization is often required to support limb salvage in ischemic cases), makes blanket statements that are debatable (e.g., antibiotics "mandatory"), recommends hyperbaric oxygen without discussing limited evidence, and includes unsupported first‑person claims ("we have achieved good results"). It also omits concrete outcome data (limb salvage rates, healing times) from the presented study. Overall the answer is moderately helpful but incomplete and sometimes imprecise.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although radical hysterectomy is recommended in patients with endometrial cancer with suspected gross cervical involvement, the effectiveness of this treatment should be reconsidered. Although the overall survival rate after surgery was comparable among all patients, age, histological grade, peritoneal cytology status, and lymph node metastasis were found to be independent prognostic factors for overall survival. RH may not be necessary in every patient with suspected cervical involvement. The decision for radical hysterectomy should be made on an individual basis by considering the risk factors for disease recurrence and patient's quality of life. Furthermore, it should be noted that RH requires careful evaluation of the cervix and pelvic lymph nodes and carries increased risks of blood loss and urinary incontinence. Therefore, we recommend further discussion regarding the indications of radical hysterectomy in these patients.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.9
Reasoning:
The assistant's reply accurately and concisely reflects the study's main findings: type of hysterectomy was not an independent prognostic factor for survival, established prognostic factors were age/grade/peritoneal cytology/lymph node status, and radical hysterectomy was associated with greater operative burden and urinary complications. The recommendation to individualize the use of radical hysterectomy is consistent with the data; the only minor omission is not explicitly stating the authors' call for prospective studies to further evaluate surgical treatment. Overall the summary is correct and appropriately cautious.

conciseness: 0.9
Reasoning:
The assistant's reply is concise and accurately conveys the study's main conclusions: radical hysterectomy (RH) did not improve overall survival, established prognostic factors were age/grade/peritoneal cytology/lymph node status, and RH carried higher perioperative and urinary morbidity. It appropriately concludes RH may not be universally necessary and that decisions should be individualized. Minor omissions: it could more explicitly state there was no survival or PFS benefit and emphasize the authors' call for prospective studies.

relevance: 0.9
Reasoning:
The assistant's reply is relevant and accurately reflects key findings from the provided context: it states that overall survival was comparable across hysterectomy types, correctly lists the independent prognostic factors (age, grade, peritoneal cytology, lymph node status), and notes higher perioperative morbidity with radical hysterectomy (longer operations, more transfusions and urinary complications). It appropriately concludes that radical hysterectomy may not be necessary for all patients and that decisions should be individualized. Minor issues: it paraphrases "severe urinary tract dysfunction" as "urinary incontinence" and adds a brief recommendation about evaluating cervix and pelvic nodes that is not explicitly stated in the excerpt, but these do not materially reduce relevance.

coherence: 0.8
Reasoning:
The assistant's reply is coherent and well-structured: it succinctly summarizes the study's main findings (no clear survival benefit from RH, established prognostic factors) and notes increased perioperative and urinary complications with RH, and it gives a reasonable clinical takeaway (individualized decision-making and need for further evaluation). Minor issues: it omits mention of progression-free and local recurrence outcomes specifically, slightly generalizes the adverse-event description, and includes a mild recommendation tone rather than strictly restating the study conclusions. Overall the answer is a clear, concise synthesis of the provided data.

helpfulness: 0.8
Reasoning:
The assistant's reply is generally accurate and helpful: it correctly conveys the main findings that radical hysterectomy (RH) showed no survival benefit compared with less extensive hysterectomies and that age, grade, peritoneal cytology, and lymph node status were independent prognostic factors. It also appropriately notes increased operative risk (blood loss/transfusion and urinary tract dysfunction) with RH and sensibly recommends individualized decision-making and further evaluation.

Minor shortcomings: it omits explicit mention that progression-free survival/local recurrence were also not independently affected by hysterectomy type, and it does not state the specific perioperative findings reported (longer operative time and higher transfusion rates) or explicitly call for prospective studies as the ground truth does. The comment that RH “requires careful evaluation of the cervix and pelvic lymph nodes” is reasonable clinical advice but is not a direct result from the study.

Overall, a concise, mostly accurate, and useful summary with small omissions.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Hospital readmissions after PD are a serious concern and are largely driven by poor postoperative outcomes. Efforts should be directed toward improving postoperative care, especially during the initial hospital stay. These efforts may include early mobilization, adequate nutrition, and timely management of complications. Further studies are warranted to identify optimal strategies to reduce hospital readmissions after PD. Surgeons should consider developing a multidisciplinary team approach to improve patient outcomes. Moreover, the development of standardized protocols for postoperative care will help optimize patient recovery. Future research should focus on identifying potential risk factors for readmission so that prophylactic interventions can be implemented to reduce the need for readmissions. This multifaceted approach is necessary to ensure optimal patient outcomes and minimize the financial burden of hospital readmissions. Finally, further investigation is needed to determine whether the readmission rate after PD is influenced by the surgeon's experience level and whether the impact of this variable varies depending on the institution.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant's reply is generic and offers reasonable high-level prevention strategies (multidisciplinary care, standardized protocols, early mobilization, nutrition), but it fails to state the study's key, specific findings. The original data showed that complexity of the initial resection (multivisceral resection) and pancreatic fistula were independently associated with readmission, and that roughly 50% of readmissions occurred within 7 days — indicating prevention efforts should especially target early readmissions. The response does not mention these primary predictors or the emphasis on preventing early (≤7-day) readmissions, nor does it reference the study's observed increase in readmission rate over the decade. For those reasons the answer is incomplete and does not accurately reflect the most important conclusions of the study.

conciseness: 0.3
Reasoning:
The response is not concise: it repeats generic recommendations (e.g., "further studies," multidisciplinary teams, standardized protocols) without directly stating the key, study-specific predictors or the most actionable finding (that pancreatic fistula and complex/multivisceral resection independently predict readmission, and that half of readmissions occur within 7 days). It therefore fails to give a brief, focused answer tied to the presented data and is somewhat redundant.

relevance: 0.3
Reasoning:
Explanation: The assistant's reply gives sensible, general strategies to reduce readmissions after PD (improved postoperative care, multidisciplinary teams, standardized protocols), but it fails to refer to or quote specific findings from the provided context. It does not mention the study's key predictors (pancreatic fistula, complexity/multivisceral resection, prolonged initial stay, ICU admission) nor the important point that half of readmissions occur within 7 days. Because the response is generic and not grounded in the given context, its relevance to the question as asked is limited.

coherence: 0.6
Reasoning:
The assistant's reply is generally coherent and organized: it outlines sensible, high-level interventions (multidisciplinary care, standardized protocols, nutrition, mobilization) and calls for further study. However, it is overly generic and fails to incorporate key, specific findings from the study (notably that pancreatic fistula and complexity of the initial resection/multivisceral resection were independent predictors of readmission, and that roughly half of readmissions occur within 7 days — so efforts should especially target early readmissions). The response also repeats broad research recommendations rather than translating the study's concrete results into targeted prevention strategies (e.g., monitoring and early management of pancreatic fistula, focused peri-discharge interventions during the first week).

helpfulness: 0.3
Reasoning:
The assistant's reply is generic and suggests reasonable broad strategies (multidisciplinary care, standardized protocols, better postoperative management), but it fails to reference or use the specific, evidence-based findings from the study. The response does not identify the independent predictors of readmission reported (pancreatic fistula and complexity of resection such as multivisceral resection, longer initial LOS, and ICU admission), nor does it note that half of readmissions occur within 7 days and that prevention efforts should target early readmissions. It also recommends further risk-factor identification even though the study already provided several. Overall the answer is not sufficiently specific or evidence-linked to be a helpful summary of this research.

================================================================================
Average correctness Score: 0.54
Average conciseness Score: 0.47
Average relevance Score: 0.545
Average coherence Score: 0.6
Average helpfulness Score: 0.515
